Isotope-dilution method for the determination of 1-vinyl-2-pyrrolidone-mercapturic acid as a potential human biomarker for 1-vinyl-2-pyrrolidone via online SPE ESI-LC/MS/MS in negative ionization mode.

[1]  F. Otero-Espinar,et al.  Drug loading optimization and extended drug delivery of corticoids from pHEMA based soft contact lenses hydrogels via chemical and microstructural modifications. , 2015, International journal of pharmaceutics.

[2]  T. Schettgen,et al.  Accurate quantification of the mercapturic acids of acrylonitrile and its genotoxic metabolite cyanoethylene-epoxide in human urine by isotope-dilution LC-ESI/MS/MS. , 2012, Talanta.

[3]  S. Weber,et al.  N-vinylpyrrolidone dimer (VPD), a novel excipient for oral drugs: repeat-dose oral toxicity in Sprague-Dawley rats. , 2012, Toxicology letters.

[4]  T. Schettgen,et al.  Accurate quantification of mercapturic acids of styrene (PHEMAs) in human urine with direct sample injection using automated column-switching high-performance liquid chromatography coupled with tandem mass spectrometry , 2010, Analytical and bioanalytical chemistry.

[5]  F. Alanazi,et al.  Acyclovir Liposomes for Intranasal Systemic Delivery: Development and Pharmacokinetics Evaluation , 2008, Drug delivery.

[6]  R. T. Pijls,et al.  Capacity and tolerance of a new device for ocular drug delivery. , 2007, International journal of pharmaceutics.

[7]  G. Feldmann,et al.  Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy , 2007, Journal of nanobiotechnology.

[8]  J. Angerer,et al.  Acrylamide exposure via the diet: influence of fasting on urinary mercapturic acid metabolite excretion in humans , 2006, Archives of Toxicology.

[9]  J. Leroux,et al.  Novel Polymeric Micelles Based on the Amphiphilic Diblock Copolymer Poly(N-vinyl-2-pyrrolidone)-block-poly(D,L-lactide) , 2001, Pharmaceutical Research.

[10]  B. Jönsson,et al.  Biological monitoring of N-methyl-2-pyrrolidone using 5-hydroxy-N-methyl-2-pyrrolidone in plasma and urine as the biomarker. , 2000, Scandinavian journal of work, environment & health.

[11]  B. Jönsson,et al.  Determination of 5-hydroxy-N-methylpyrrolidone and 2-hydroxy-N-methylsuccinimide in human urine. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[12]  B. Jönsson,et al.  Major metabolic pathway for N-methyl-2-pyrrolidone in humans. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[13]  M. Strube,et al.  [Preparation and testing of polymer drugs. 4. Water-soluble polymer drugs with a base of vinylpyrrolidone-maleic acid anhydride-copolymers]. , 1988, Die Pharmazie.

[14]  K. Norpoth,et al.  Urinary excretion of acrylonitrile and its metabolites in rats , 1987, Archives of Toxicology.

[15]  M. D. Blanco,et al.  Controlled release of cytarabine from poly(2-hydroxyethyl methacrylate-co-N-vinyl-2-pyrrolidone) hydrogels. , 1997, Journal of biomaterials science. Polymer edition.

[16]  T. Fennell,et al.  Characterization and quantitation of urinary metabolites of [1,2,3-13C]acrylamide in rats and mice using 13C nuclear magnetic resonance spectroscopy. , 1992, Chemical research in toxicology.